| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 8.12▼ | 8.16▼ | 8.17▼ | 8.23▼ | 7.37▲ |
| MA10 | 8.14▼ | 8.19▼ | 8.19▼ | 7.57▲ | 7.15▲ |
| MA20 | 8.16▼ | 8.20▼ | 8.21▼ | 7.19▲ | 6.64▲ |
| MA50 | 8.21▼ | 8.25▼ | 7.83▲ | 6.90▲ | 6.28▲ |
| MA100 | 8.22▼ | 7.74▲ | 7.31▲ | 6.52▲ | 6.55▲ |
| MA200 | 8.25▼ | 7.28▲ | 7.05▲ | 6.35▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.004▼ | -0.013▼ | -0.045▼ | 0.146▲ | 0.152▲ |
| RSI | 39.247▼ | 43.034▼ | 49.941▼ | 70.533▲ | 64.177▲ |
| STOCH | 19.537▼ | 26.015 | 47.013 | 87.377▲ | 68.982 |
| WILL %R | -83.333▼ | -74.026 | -74.026 | -25.624 | -13.176▲ |
| CCI | -100.832▼ | -135.721▼ | -165.377▼ | 89.649 | 196.105▲ |
|
Saturday, June 21, 2025 05:00 PM
Find annual and quearterly earnings data for Lifecore Biomedical, Inc. Common Stock (LFCR) including earnings per share, earnings forecasts at Nasdaq.com.
|
|
Wednesday, June 18, 2025 12:26 AM
Lifecore Biomedical is emerging from a challenging restructuring and is now a pure play CDMO with new management. Read more on LFCR stock here.
|
|
Tuesday, June 17, 2025 08:39 PM
Tuesday, LFCR rose 2.10% to close at $6.81 and slipped 1.76% after hours to end at $6.69 on the NasdaqGS. The views and opinions expressed herein are the views and opinions of the author and do ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/06/25 | 8.16 | 8.39 | 8.01 | 8.12 | 576,417 |
| 27/06/25 | 8.26 | 8.36 | 8.01 | 8.19 | 946,415 |
| 26/06/25 | 8.40 | 8.6299 | 8.17 | 8.23 | 174,696 |
| 25/06/25 | 8.37 | 8.4483 | 8.17 | 8.34 | 196,259 |
| 24/06/25 | 7.52 | 8.29 | 7.481 | 8.28 | 354,992 |
| 23/06/25 | 6.95 | 7.40 | 6.95 | 7.39 | 228,576 |
| 20/06/25 | 6.77 | 6.95 | 6.64 | 6.94 | 168,447 |
| 18/06/25 | 6.80 | 6.80 | 6.675 | 6.71 | 75,762 |
| 17/06/25 | 6.82 | 6.925 | 6.74 | 6.81 | 231,294 |
| 16/06/25 | 6.80 | 6.87 | 6.64 | 6.67 | 98,702 |
|
|
||||
|
|
||||
|
|